JAFCO Super V3 Investment Limited Partnership's Net Worth

$3.58 Million

Estimate Recalculated Nov 3, 2024 09:37PM EST

Who is JAFCO Super V3 Investment Limited Partnership?

JAFCO Super V3 Investment Limited Partnership has an estimated net worth of $3.58 Million. This is based on reported shares across multiple companies, which include Eleven Biotherapeutics, Inc., and Tracon Pharmaceuticals, Inc..

SEC CIK

JAFCO Super V3 Investment Limited Partnership's CIK is 0001590442

Past Insider Trading and Trends

2014 was JAFCO Super V3 Investment Limited Partnership's most active year for acquiring shares with 5 total transactions. JAFCO Super V3 Investment Limited Partnership's most active month to acquire stocks was the month of January. 2015 was JAFCO Super V3 Investment Limited Partnership's most active year for disposing of shares, totalling 110 transactions. JAFCO Super V3 Investment Limited Partnership's most active month to dispose stocks was the month of December. 2015 saw JAFCO Super V3 Investment Limited Partnership paying a total of $2,579,500.00 for 1,817,670 shares, this is the most they've acquired in one year. In 2015 JAFCO Super V3 Investment Limited Partnership cashed out on 6,561,337 shares for a total of $6,175,040.70, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Eleven Biotherapeutics, Inc. (CARM) Snapshot price: $0.9803

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.71%
-33.40K
$13.23
-$441,882.00
1.92M
May 8
Form 4
-0.11%
-2.20K
$11.66
-$25,652.00
1.96M
Jan 27
Form 4
-0.91%
-17.90K
$11.62
-$207,998.00
1.96M
Feb 2
Form 4
-5.72%
-120.00K
$11.62
-$1,394,400.00
1.98M
Jan 28 - Jan 30
Form 4
-0.30%
-6.30K
$11.85
-$74,667.50
2.1M
Jan 23 - Jan 26
Form 4
-0.30%
-6.30K
$11.82
-$74,490.53
2.1M
Jan 21 - Jan 22
Form 4
-0.29%
-6.10K
$12.07
-$73,654.56
2.11M
Jan 15 - Jan 16
Form 4
-0.19%
-4.10K
$12.48
-$51,171.90
2.12M
Jan 13
Form 4
-0.09%
-2.00K
$11.54
-$23,070.00
2.12M
Aug 25 - Aug 26
Form 4
-0.05%
-1.17K
$11.54
-$13,447.50
2.12M
Aug 19 - Aug 20
Form 4
-0.12%
-2.60K
$11.81
-$30,694.00
2.12M
Aug 15 - Aug 18
Form 4
-0.09%
-2.00K
$11.75
-$23,500.55
2.13M
Aug 13 - Aug 14
Form 4
∞
2.13M
$10.00
—
2.13M
Feb 11
Form 3
—
0
—
—
0
No matching records found

Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.13925

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.10%
-1.50K
$9.90
-$14,848.50
1.5M
Oct 16
Form 4
-0.35%
-5.30K
$10.16
-$53,826.27
1.5M
Oct 15
Form 4
-0.21%
-3.17K
$10.01
-$31,710.95
1.5M
Oct 9 - Oct 13
Form 4
-1.43%
-21.92K
$10.10
-$221,374.94
1.51M
Oct 7 - Oct 8
Form 4
-0.98%
-15.10K
$10.08
-$152,255.80
1.53M
Oct 2 - Oct 5
Form 4
-0.49%
-7.60K
$12.13
-$92,163.68
1.54M
Sep 25
Form 4
-1.42%
-22.30K
$12.99
-$289,745.90
1.55M
Sep 23 - Sep 24
Form 4
-2.44%
-39.43K
$14.02
-$552,736.17
1.57M
Sep 21 - Sep 22
Form 4
-2.56%
-42.34K
$11.78
-$498,927.56
1.61M
Sep 15 - Sep 17
Form 4
-3.50%
-60.04K
$11.78
-$707,012.48
1.66M
Sep 10 - Sep 14
Form 4
-1.40%
-24.30K
$10.59
-$257,408.94
1.72M
Sep 4 - Sep 9
Form 4
-0.87%
-15.30K
$10.51
-$160,838.66
1.74M
Sep 2 - Sep 3
Form 4
-0.79%
-14.00K
$10.42
-$145,937.60
1.76M
Aug 31 - Sep 1
Form 4
-0.17%
-3.00K
$11.00
-$33,000.00
1.77M
Aug 24
Form 4
-0.60%
-10.68K
$11.36
-$121,390.87
1.77M
Aug 19 - Aug 20
Form 4
-0.62%
-11.17K
$11.71
-$130,811.14
1.78M
Aug 14 - Aug 18
Form 4
-0.52%
-9.36K
$11.60
-$108,570.77
1.79M
Aug 12 - Aug 13
Form 4
-0.32%
-5.80K
$11.40
-$66,146.00
1.8M
Aug 11 - Aug 12
Form 4/A
-0.46%
-8.30K
$11.59
-$96,209.00
1.81M
Aug 7 - Aug 10
Form 4
-0.53%
-8.30K
$11.59
-$96,209.00
1.55M
Aug 7 - Aug 10
Form 4/A
+16.54%
257.95K
$10.00
$2,579,500.00
1.82M
Feb 4
Form 4
∞
1.56M
—
—
1.56M
Feb 4
Form 3
—
0
—
—
0
No matching records found